Back
23
Day Range
$108.81
$111.41
52-Week Range
$102.31
$141.78
Volume
456,763
50D / 200D Avg
$115.61
/
$120.81
Prev Close
$109.16
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 9.6 | 10.4 |
| P/B | 1.6 | 1.2 |
| ROE % | 17.8 | 12.6 |
| Net Margin % | 10.1 | 5.3 |
| Rev Growth 5Y % | 1.2 | 5.5 |
| D/E | 0.4 | 0.6 |
Key Takeaways
Revenue grew 1.16% annually over 5 years — modest growth
ROE of 17.78% — decent returns on equity
Debt/Equity of 0.41 — conservative balance sheet
Generating 511.00M in free cash flow
P/E of 9.63 — trading at a low valuation
PEG of 0.65 suggests growth is underpriced
Growth
Revenue Growth (5Y)
1.16%
Revenue (1Y)-2.84%
Earnings (1Y)12.67%
FCF Growth (3Y)-16.96%
Quality
Return on Equity
17.78%
ROIC12.40%
Net Margin10.10%
Op. Margin14.03%
Safety
Debt / Equity
0.41
Current Ratio2.66
Interest Coverage27.38
Valuation
P/E Ratio
9.63
P/B Ratio1.62
EV/EBITDA7.68
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -2.84% | Revenue Growth (3Y) | -5.94% |
| Earnings Growth (1Y) | 12.67% | Earnings Growth (3Y) | 6.48% |
| Revenue Growth (5Y) | 1.16% | Earnings Growth (5Y) | 57.99% |
| Profitability | |||
| Revenue (TTM) | 7.22B | Net Income (TTM) | 729.00M |
| ROE | 17.78% | ROA | 9.23% |
| Gross Margin | 25.32% | Operating Margin | 14.03% |
| Net Margin | 10.10% | Free Cash Flow (TTM) | 511.00M |
| ROIC | 12.40% | FCF Growth (3Y) | -16.96% |
| Safety | |||
| Debt / Equity | 0.41 | Current Ratio | 2.66 |
| Interest Coverage | 27.38 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 9.63 | P/B Ratio | 1.62 |
| P/S Ratio | 0.97 | PEG Ratio | 0.65 |
| EV/EBITDA | 7.68 | Dividend Yield | 0.03% |
| Market Cap | 7.02B | Enterprise Value | 7.78B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7.22B | 7.43B | 8.16B | 7.95B | 6.89B |
| Net Income | 729.00M | 647.00M | 643.00M | 492.00M | 117.00M |
| EPS (Diluted) | 11.18 | 9.71 | 9.60 | 7.34 | 1.73 |
| Gross Profit | 1.83B | 1.79B | 1.75B | 1.49B | 1.33B |
| Operating Income | 1.01B | 883.00M | 957.00M | 762.00M | 310.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 7.90B | 7.44B | 7.64B | 7.56B | 7.00B |
| Total Liabilities | 3.53B | 3.55B | 3.99B | 4.30B | 3.77B |
| Shareholders' Equity | 4.34B | 3.86B | 3.59B | 3.20B | 3.14B |
| Total Debt | 1.79B | 2.04B | 2.40B | 2.68B | 2.25B |
| Cash & Equivalents | 1.03B | 997.00M | 401.00M | 236.00M | 328.00M |
| Current Assets | 3.51B | 3.36B | 3.40B | 3.31B | 2.70B |
| Current Liabilities | 1.32B | 1.28B | 1.77B | 1.88B | 1.51B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#384 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026